| Impact of pulse characteristics on atrial defibrillation energy requirements. | |
| | |
MedLine Citation:
|
PMID: 7518593 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
In summary, many issues pertaining to pulse characteristics and atrial defibrillation remain unsolved. Perhaps the most burning questions are whether a further reduction in atrial defibrillation energy requirements can be achieved by the combination of biphasic waveforms with dual pathway sequential shocks to produce a more homogenous distribution of charge, whether right and left atrial polarity of the first phase of asymmetrical biphasic shocks can reduce energy requirements in individual patients and whether the delivery of very long biphasic shocks (possibly > 20 msec) can reduce the discomfort of shorter shocks by decreasing the peak current density. Only then will the wide-spread acceptance of the implantable atrial defibrillator become closer to reality. |
| | |
Authors:
|
D Keane |
Related Documents
:
|
14118683 - Cardiac resuscitation--the present status of defibrillation and stimulation techniques. 20650333 - Electrophysiology-guided defibrillator implantation early after st-elevation myocardial... 8339413 - Myocardial blood flow distribution in patients with ischemic heart disease or dilated c... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Pacing and clinical electrophysiology : PACE Volume: 17 ISSN: 0147-8389 ISO Abbreviation: Pacing Clin Electrophysiol Publication Date: 1994 May |
Date Detail:
|
Created Date: 1994-08-15 Completed Date: 1994-08-15 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 7803944 Medline TA: Pacing Clin Electrophysiol Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 1048-57 Citation Subset: IM |
Affiliation:
|
Thoraxcenter, Erasmus University, Rotterdam, The Netherlands. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Anti-Arrhythmia Agents / therapeutic use Atrial Fibrillation / therapy* Defibrillators, Implantable Electric Countershock* Electrocardiography Electrodes, Implanted Heart Atria Heart Block / epidemiology Humans Risk Factors Ventricular Fibrillation / epidemiology |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Arrhythmia Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Lead systems for atrial defibrillation.
Next Document: Detection of occult micrometastases in the bone marrow of patients with prostate carcinoma.